quinazolines has been researched along with Insulin Sensitivity in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (13.33) | 18.2507 |
2000's | 3 (20.00) | 29.6817 |
2010's | 10 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aroor, AR; Bender, SB; Demarco, VG; Garro, M; Hayden, MR; Johnson, MS; Mugerfeld, I; Nistala, R; Salam, M; Sowers, JR; Whaley-Connell, A | 1 |
Benterki, I; Fontés, G; Peyot, ML; Poitout, V; Prentki, M; Seda, O; Zarrouki, B | 1 |
Kontani, Y; Kusudo, T; Mori, N; Okamatsu, Y; Saito, M; Takeuchi, T; Wang, T; Yamashita, H; Yamashita, Y | 1 |
Chen, ZF; Guo, WW; Li, Z; Liu, LH; Wu, GY; Xie, JY; Yi, JY; Zhang, L; Zhang, ZJ | 1 |
Chan, KC; Chen, ML; Huang, CN; Peng, CH; Wang, CJ; Yang, YS | 1 |
Bian, K; Nie, XQ; Shi, HX; Yang, JW; Yuan, Y; Zhang, JY; Zhang, YJ | 1 |
Yamashita, H | 1 |
Carvalheira, JB; Cintra, DE; de Souza, CT; Franchini, KG; Mourão, RH; Pauli, JR; Prada, PO; Rittner, R; Rocco, SA; Ropelle, ER; Saad, MJ; Schenka, A; Vassallo, J; Velloso, LA | 1 |
Arellano-Plancarte, A; Catt, KJ; Hernandez-Aranda, J; Olivares-Reyes, JA | 1 |
Li, YX; Sun, Q; Wang, H; Wang, SN | 1 |
Akanuma, M; Fujiya, M; Hiranaka, N; Ieko, M; Kanazawa, K; Kohgo, Y; Naito, S; Oka, K; Suzuki, T; Takahashi, N; Yoshida, M; Yoshizaki, T; Yui, T | 1 |
Blüher, M; Kern, M; Klein, T; Klöting, N; Mark, M; Niessen, HG; Stiller, D; Thomas, L | 1 |
Ihara, S; Kawana, M; Sakai, R; Shimamoto, K; Watanabe, H | 1 |
Hara, Y; Harano, Y; Kanazawa, A; Nishioheda, Y; Ryomoto, K; Shinozaki, K; Suzuki, M; Tsushima, M | 1 |
Asakura, Y; Harano, Y; Hirose, J; Kageyama, A; Omae, T; Sato, A; Suzuki, M | 1 |
1 trial(s) available for quinazolines and Insulin Sensitivity
Article | Year |
---|---|
An alpha1-receptor blocker reduces plasma leptin levels in hypertensive patients with obesity and hyperleptinemia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; Body Mass Index; Delayed-Action Preparations; Fatty Acids, Nonesterified; Female; Heart Rate; Humans; Hypertension; Insulin Resistance; Leptin; Male; Middle Aged; Obesity; Quinazolines; Receptors, Leptin; Treatment Outcome | 2006 |
14 other study(ies) available for quinazolines and Insulin Sensitivity
Article | Year |
---|---|
Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats.
Topics: Animals; Blood Pressure; Body Weight; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Eating; Insulin Resistance; Linagliptin; Male; Myocardium; Nitric Oxide Synthase Type III; Purines; Quinazolines; Rats; Rats, Zucker; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2013 |
Epidermal growth factor receptor signaling promotes pancreatic β-cell proliferation in response to nutrient excess in rats through mTOR and FOXM1.
Topics: Animals; Cell Cycle; Cell Proliferation; Cells, Cultured; ErbB Receptors; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Expression Profiling; Insulin Resistance; Insulin-Secreting Cells; Male; Quinazolines; Rats; Rats, Wistar; Signal Transduction; TOR Serine-Threonine Kinases; Tyrphostins | 2014 |
Evodiamine inhibits insulin-stimulated mTOR-S6K activation and IRS1 serine phosphorylation in adipocytes and improves glucose tolerance in obese/diabetic mice.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue, White; AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Experimental; Evodia; Female; Glucose; Glucose Tolerance Test; Hypoglycemic Agents; Insulin Receptor Substrate Proteins; Insulin Resistance; Mice; Mice, Obese; Phosphorylation; Quinazolines; Ribosomal Protein S6 Kinases; Serine; Signal Transduction; TOR Serine-Threonine Kinases | 2013 |
Evodiamine activates AMPK and promotes adiponectin multimerization in 3T3-L1 adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; AMP-Activated Protein Kinases; Animals; Calcium; Evodia; Insulin Resistance; Mice; Molecular Structure; Molecular Weight; Phosphatidylinositol 3-Kinases; Quinazolines; Signal Transduction | 2014 |
Hibiscus sabdariffa polyphenols alleviate insulin resistance and renal epithelial to mesenchymal transition: a novel action mechanism mediated by type 4 dipeptidyl peptidase.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Epithelial-Mesenchymal Transition; Glucose; Hibiscus; Insulin Receptor Substrate Proteins; Insulin Resistance; Kidney; Linagliptin; Male; Phosphorylation; Polyphenols; Purines; Quinazolines; Rats, Sprague-Dawley; Vimentin | 2014 |
[Effects of rutaecarpine on inflammatory cytokines in insulin resistant primary skeletal muscle cells].
Topics: Animals; Cell Proliferation; Cytokines; Female; Glucose; Indole Alkaloids; Inflammation; Insulin Resistance; Male; Muscle, Skeletal; Quinazolines; Rats | 2014 |
A natural compound Evo(kes) signaling for fat regulation.
Topics: Animals; Female; Insulin Receptor Substrate Proteins; Insulin Resistance; Quinazolines; Ribosomal Protein S6 Kinases; TOR Serine-Threonine Kinases | 2014 |
EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice.
Topics: Adiponectin; Adipose Tissue; Animals; Blood Glucose; Dietary Fats; Enzyme Inhibitors; ErbB Receptors; Gene Expression Regulation, Enzymologic; Glucose Tolerance Test; Hypoglycemic Agents; Immunoblotting; Immunoprecipitation; Inflammation; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Leptin; Liver; Macrophages; Male; Mice; Muscle, Skeletal; NF-kappa B p50 Subunit; Nitric Oxide Synthase Type II; Phosphorylation; Protein-Tyrosine Kinases; Quinazolines; Signal Transduction; Tumor Necrosis Factor-alpha | 2009 |
Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells.
Topics: Angiotensin II; Animals; Cell Line; Enzyme Inhibitors; ErbB Receptors; Hepatocytes; Insulin; Insulin Resistance; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines; Rats; Receptor, Insulin; Serine; Signal Transduction; Threonine; Transcriptional Activation; Tyrphostins; Vasoconstrictor Agents | 2010 |
[Gefitinib improves insulin sensitivity in Wistar diabetes rats models].
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gefitinib; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Phosphatidylinositol 3-Kinases; Quinazolines; Rats; Rats, Wistar | 2009 |
Suppression of lipin-1 expression increases monocyte chemoattractant protein-1 expression in 3T3-L1 adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Chemokine CCL2; Chemotaxis; Gene Expression; Insulin Resistance; Mice; NF-kappa B; Nuclear Proteins; Obesity; Phosphatidate Phosphatase; Protein Biosynthesis; Quinazolines; RNA, Messenger; RNA, Small Interfering; Salicylates | 2011 |
Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity.
Topics: Adipose Tissue; Animals; Diet; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fatty Liver; Female; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Insulin; Insulin Resistance; Linagliptin; Liver; Mice; Mice, Inbred C57BL; Obesity; Purines; Quinazolines | 2012 |
Clinical impact of insulin resistance syndrome in cardiovascular diseases and its therapeutic approach.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Cilazapril; Humans; Insulin Resistance; Middle Aged; Quinazolines | 1996 |
Insulin insensitivity in nonobese, nondiabetic essential hypertension and its improvement by an alpha 1-blocker (bunazosin).
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Apoproteins; Blood Glucose; Blood Pressure; Catecholamines; Diabetes Mellitus; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Resistance; Lipids; Male; Middle Aged; Obesity; Quinazolines; Sodium | 1992 |